Stephen Krieger, MD
- ASSOCIATE PROFESSOR | Neurology
Specialty:
Neurology
Dr. Stephen Krieger joined The Corinne Goldsmith Dickinson Center for MS as a fellow in multiple sclerosis after completing his neurology residency training at Mount Sinai. He was the recipient of a 2006 American Academy of Neurology Scholarship and received a Sylvia Lawry Fellowship in clinical research from the National Multiple Sclerosis Society. He graduated summa cum laude from Columbia College, and received his MD degree from Yale University. Dr. Krieger has a clinical practice at the Center, and has participated in numerous MS clinical trials, including oral therapies and monoclonal antibodies used as disease-modifying agents for MS. In addition to his clinical work, he has an academic appointment as Associate Professor of Neurology at the Icahn School of Medicine at Mount Sinai, where he is Director of the Neurology Residency Training program. Dr. Krieger was elected as a Faculty Member of Alpha Omega Alpha and inducted as a Fellow into the Institute for Medical Education in 2011, and has received several subsequent teaching and mentorship awards including the George Forster Compassion Award in 2014. Dr. Krieger is on several advisory boards and steering committees in the field of Multiple Sclerosis, and is an active member of the American Academy of Neurology (AAN) who awarded him an A.B. Baker teaching recognition award in 2010. He has presented original work at AAN, CMSC, ACTRIMS, and ECTRIMS and has written review articles on and lectures nationally about MS with an emphasis on underdtanding disease course and emerging therapies. In 2015 Dr. Krieger proposed the Topographical Model of MS, a new conceptualization of MS disease course that was accepted for presentation at several national/international meetings, was the cover article of the October 2016 issue of Neurology: Neuroimmunology & Neuroinflammation and was the subject of an article in Scientific American. An iPad app version of this work called "MS Topography", designed for patient and clinician education, is available at no charge on the Apple App Store for iPad.
Clinical Focus
- Multiple Sclerosis
- Neuromyelitis Optica
Education
MD, Yale University School of Medicine
Internship, Internal Medicine, St. Vincent's Hosp. Med. Ctr. of NY
Residency, Neurology, Mount Sinai Hospital
Fellowship, Multiple Sclerosis, Mount Sinai Hospital
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B. Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. The New England journal of medicine 2018 08; 379(9).
Shoirah H, Ntranos A, Brandstadter R, Liu Y, Medina E, Kwan J, Krieger S. Education Research: Resident education through adult learning in neurology: Implementation and impact. Neurology 2018 Jul; 91(5).
Krieger SC, Cook K, De Nino S, Fletcher M. The topographical model of multiple sclerosis: A dynamic visualization of disease course. Neurology(R) neuroimmunology & neuroinflammation 2016 Oct; 3(5).
Krieger SC. New Approaches to the Diagnosis, Clinical Course, and Goals of Therapy in Multiple Sclerosis and Related Disorders. Continuum (Minneapolis, Minn.) 2016 06; 22(3).
Krieger S. Multiple sclerosis therapeutic pipeline: opportunities and challenges. The Mount Sinai journal of medicine, New York; 78(2).
Sand IK, Krieger S, Farrell C, Miller AE. Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 2014 Feb;.
Krieger S, Sorrells SF, Nickerson M, Pace TW. Mechanistic insights into corticosteroids in multiple sclerosis: war horse or chameleon?(☆). Clinical neurology and neurosurgery 2014 Apr; 119.
Oynhausen S, Alcauskas M, Hannigan C, Bencosme Y, Müller M, Lublin F, Krieger S. Emergency medical care of multiple sclerosis patients: primary data from the mount sinai resource utilization in multiple sclerosis project. Journal of clinical neurology (Seoul, Korea) 2014 Jul; 10(3).
Farber R, Hannigan C, Alcauskas M, Krieger S. Emergency Department visits before the diagnosis of MS. Multiple sclerosis and related disorders 2014 May; 3(3).
Clardy SL, Lucchinetti CF, Krecke KN, Lennon VA, O'Toole O, Weinshenker BG, Boyd CD, Krieger S, McGraw C, Guo Y, Pittock SJ. Hydrocephalus in neuromyelitis optica. Neurology 2014 May; 82(20).
Miller AE, Cohen BA, Krieger SC, Markowitz CE, Mattson DH, Tselentis HN. Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME. Multiple sclerosis (Houndmills, Basingstoke, England) 2013 Aug;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Krieger during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Acorda Therapeutics Inc.; Biogen Idec; Genentech, Inc.; Genzyme Corporation; Novartis; Questcor Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Ltd.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Genzyme Corporation
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- Gerson Lehrman Group
Scientific Advisory Board:
- Bayer; Biogen Idec; Questcor Pharmaceuticals, Inc.; Teva Pharmaceutical Industries Ltd.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.